CiteULike is a free online bibliography manager. Register and you can start organising your references online.
Tags

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

by: Ricky W. Johnstone
Nature Reviews Drug Discovery, Vol. 1, No. 4. (01 April 2002), pp. 287-299, doi:10.1038/nrd772  Key: citeulike:11865443

Formatted Citation


Show HTML

Likes (beta)

This copy of the article hasn't been liked by anyone yet.

View FullText article


Abstract

The opposing actions of histone acetyltransferases (HATs) and histone deacetylases (HDACs) allow gene expression to be exquisitely regulated through chromatin remodelling. Aberrant transcription due to altered expression or mutation of genes that encode HATs, HDACs or their binding partners, is a key event in the onset and progression of cancer. HDAC inhibitors can reactivate gene expression and inhibit the growth and survival of tumour cells. The remarkable tumour specificity of these compounds, and their potency in vitro and in vivo, underscore the potential of HDAC inhibitors as exciting new agents for the treatment of cancer.


mikeisnaked's tags for this article

Citations (CiTO)

No CiTO relationships defined

X There are no reviews yet

X Find related articles with these CiteULike tags

X Posting History


X Export records

Privacy Statement | Terms & Conditions
CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.